mebendazole has been researched along with Dry Macular Degeneration in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Q | 1 |
| Presswalla, F | 1 |
| Ali, RR | 1 |
| Zacks, DN | 1 |
| Thompson, DA | 1 |
| Miller, JML | 1 |
1 other study available for mebendazole and Dry Macular Degeneration
| Article | Year |
|---|---|
Pharmacologic activation of autophagy without direct mTOR inhibition as a therapeutic strategy for treating dry macular degeneration.
Topics: Aborted Fetus; Autophagy; Cells, Cultured; Drug Evaluation, Preclinical; Geographic Atrophy; Humans; | 2021 |